0000886163-22-000125.txt : 20220922
0000886163-22-000125.hdr.sgml : 20220922
20220922203250
ACCESSION NUMBER: 0000886163-22-000125
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220916
FILED AS OF DATE: 20220922
DATE AS OF CHANGE: 20220922
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HIGGINS JOHN L
CENTRAL INDEX KEY: 0001208906
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 221260442
MAIL ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4/A
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4/A
2022-09-16
2022-09-16
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001208906
HIGGINS JOHN L
5980 HORTON STREET, SUITE 405
EMERYVILLE
CA
94608
1
1
0
0
Chief Executive Officer
Common Stock
2022-09-16
4
S
0
1000
88.06
D
366180
D
On September 16, 2022, due to an issue with the equity administration system of the company, the reporting person filed a Form 4 which inadvertently reported the sale of a higher number of shares than were actually sold by the reporting person. The correct number of shares sold is listed above.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.05 to $88.12, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
By: Charles S. Berkman For: John L. Higgins
2022-09-22